Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; generally known as FRAP-linked protein (FRP1)) has emerged being a promising method for cancer remedy that exploits artificial lethal interactions with proteins associated with DNA damage fix, overcomes resistance to other therapies and boosts antitumour immunity. Various ... https://geoffreys907zmf0.webbuzzfeed.com/profile